Show simple item record

AuthorDöhner, Hartmutdc.contributor.author
AuthorMueller-Tidow, Carstendc.contributor.author
AuthorLuebbert, Michaeldc.contributor.author
AuthorFiedler, Walterdc.contributor.author
AuthorKraemer, Alwindc.contributor.author
AuthorWestermann, Joergdc.contributor.author
AuthorBug, Gesinedc.contributor.author
AuthorSchlenk, Richard Friedrichdc.contributor.author
AuthorKrug, Utzdc.contributor.author
AuthorGoeldner, Rainer-Georgdc.contributor.author
AuthorHilbert, Jamesdc.contributor.author
AuthorTaube, Tillmanndc.contributor.author
AuthorOttmann, Oliver G.dc.contributor.author
Date of accession2019-09-11T08:49:17Zdc.date.accessioned
Available in OPARU since2019-09-11T08:49:17Zdc.date.available
Date of first publication2019dc.date.issued
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
TitleA phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemiadc.title
Resource typeWissenschaftlicher Artikeldc.type
InstitutionUKU. Klinik für Innere Medizin IIIuulm.affiliationSpecific
DCMI TypeTextuulm.typeDCMI
CategoryPublikationsnachweiseuulm.category
DOI (external)10.1111/bjh.15563dc.identifier.doiExternal
Source - Title of sourceBritish Journal of Haematologysource.title
Source - Place of publicationWileysource.publisher
Source - Volume185source.volume
Source - Issue3source.issue
Source - Year2019source.year
Source - From page583source.fromPage
Source - To page587source.toPage
Source - ISSN0007-1048source.identifier.issn
Source - eISSN1365-2141source.identifier.eissn
FundingBoehringer Ingelheimuulm.funding
Suitable communityUniversitätsklinikum Ulmuulm.community
WoS000465109900023uulm.identifier.wos


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record